An Effective Alternative to Injections
The typhoid fever, a bacterial infection caused by Salmonella Typhi, remains a major public health problem in many developing countries where sanitation and clean water supplies are limited. Every year over 11 million cases of typhoid fever occur globally resulting in over 128,000 deaths. Children and young adults are at highest risk. The disease is effectively treated with antibiotics but antibiotic resistance is growing. An oral vaccine can help reduce the burden of the disease worldwide.
A Safe and Effective Option
The recently WHO prequalified live attenuated oral typhoid vaccine called Typbar-TCV was developed by Bharat Biotech of India. It contains a live but weakened strain of Salmonella Typhi which does not cause disease but triggers strong immune response in the body. In clinical trials, the vaccine was found to be safe and effective in preventing typhoid fever with a single dose effectiveness of over 85% that lasted for at least 3 years. It can offer protection to children from age 6 months up to adults.
The oral vaccine is easy to administer without need of trained healthcare staff. It does not need cold chain transportation or storage like the injectable vaccines which require refrigeration. This makes the vaccine cost effective and suitable for mass immunization programs in low resource settings. The vaccine is stable at temperatures up to 40°C for four weeks and can withstand temperatures up to 100°C for short periods, facilitating use even in remote tropical areas.
Increases Access in Developing World
While injectable vaccines exist in the market, their use remains limited in developing nations due to cost and logistical challenges. The enteric fever vaccine can potentially increase vaccine access to at-risk populations in these countries. It has already been prequalified by WHO and piloted vaccination programs have shown promise. If introduced widely, it may help reduce the burden of typhoid in Asian and African regions where disease incidence is highest.
The vaccine manufacturer Bharat Biotech plans to make the oral typhoid vaccine available at an affordable price for public immunization programs. It aims to supply 25 million doses annually over the coming years. Several developing countries in Southeast Asia and Sub-Saharan Africa have expressed interest in introducing the oral vaccine in their routine immunization programs targeting school going children and young adults. Successful implementation could pave the way for controlling typhoid in these regions.
Increased Awareness and Demand
The WHO prequalification of the enteric fever vaccine is raising awareness about typhoid and the role of vaccination in prevention. It is increasing demand from disease endemic nations as well as international organizations funding immunization programs in low income settings. Global health experts project increased vaccine uptake once supply becomes widely available to fulfill the growing needs.
Meanwhile vaccination focus is shifting from travelers to at-risk local populations in endemic regions. Large effectiveness studies are ongoing in Asia and Africa to understand real world impact. Positive outcomes will provide evidence to guide vaccination policies. Data on vaccine impact, cost effectiveness and lessons from vaccination program delivery will help increase confidence in use of the oral typhoid vaccine approach over the coming years.
With focused efforts, the vaccine has potential to significantly reduce the health and economic burden of typhoid fever in developing nations. It may ultimately help eliminate the disease if used alongside other control strategies like water, sanitation and hygiene improvement programs. This simple oral vaccine could drive progress towards a typhoid-free world especially in resource constrained settings that are most impacted.
The new enteric fever vaccine delivers Immunization through a cost effective delivery mechanism suitable for both endemic areas and mass public health programs. It provides a safe alternative to existing injectable vaccines and increases opportunities to protect at risk populations from one of the leading infectious diseases affecting millions globally each year. Widespread introduction has potential for major health impact by controlling typhoid fever worldwide.
Sponsorizzato
Sponsorizzato
Cerca
Sponsorizzato
Categorie
- News
- social
- personal
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Giochi
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Altre informazioni
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
Leggi tutto
An Analysis of The Digital Personal Data Protection Bill, 2022
Following the withdrawal of the draft Personal Data Protection Bill 2019...
Methylene Chloride Market Size, Share, Analysis
Global Methylene Chloride Market size was US$ 1025.87 Mn in 2023 and is expected...
Organic Baby Food Market Size, Key Player Analysis, Share and Forecast 2023-2032
Polaris Market Research has added Organic Baby Food Market Share, Size, Trends, Industry Analysis...
Self Balancing Scooter Market Analysis of the World's Leading Suppliers, Sales, Trends and Forecasts up to 2030
Self Balancing Scooter Market Insights Unveiled:
Embark on a riveting journey through the...
Lab Grown Diamonds Market Supply and Demand with Size (Value and Volume) by 2029
Lab Grown Diamonds Market Overview
The market overview of the Lab Grown Diamonds...
Sponsorizzato
© 2024 Humwaten pakistan Ist social website Italiano